A plant of the genus Cannabis generally refers to three varieties that are Cannabis sativa, Cannabis indica and Cannabis ruderalis. Sativa and Indica are the most commonly used in cannabis strains for cultivation and propagation. The genetics of different cannabis strains are extensively mixed or cloned to create cannabis hybrids. Cannabis contains several active elements, including cannabinoids such as tetrahydrocannabinol (THC) or dronabinol, cannabidiol (CBD) and terpenes (aromatic compounds or chemical markers).
Cannabis plants with a tetrahydrocannabinol (THC) level lower than 0.3% (industrial hemp) and cannabis-based drugs are excluded from the classification group of cannabis products. Cannabis that contains very low amounts of THC in its flowers and leaves (less than 0.3%) is classified as hemp. While processing license holders can currently participate in many research and development activities, administer cannabis to a test subject (i). The Cannabis Agency states that this guarantees the availability of cannabis for medical purposes with a reproducible quality in accordance with the requirements of drug legislation.
The reclassification of cannabis and cannabis resin will remove some international procedural obstacles to the research and development of cannabis-based medical products in accordance with national regulatory frameworks. Cannabis extracts and tinctures would be removed from Schedule I of the 1961 treaty pursuant to the recommendations, and compound pharmaceutical preparations containing THC would be included in Schedule III of that convention. THC is responsible for the way the brain and body respond to cannabis, including high and intoxication. Labels on cannabis extracts should also include a list of ingredients, the identity of the cannabis product in terms of its common name or function and a list of allergens, as well as the intended use of the product (for example, other countries, such as Canada and Uruguay, which have legalized marijuana in contravention) of current treaties are likely to support the reform, as do several European and South American countries that allow medical cannabis.
To properly record and describe the economic and social aspects related to the legalization of cannabis, Statistics Canada has had to update the agency's classification systems, such as the product classification system and the industrial classification system. The agency also wants delta-9-tetrahydrocannabinol (THC) and its isomers to be completely removed from an independent drug treaty of 1971 and, instead, added to Schedule I of the 1961 Convention, according to a WHO document that has not yet been formally published but was distributed by advocates of the reform of cannabis. Until cannabis is available for medical purposes from German cultivation, demand will be met by imports (mainly from the Netherlands or Canada), for which the responsibility lies not with the Cannabis Agency but with the Federal Opium Agency. According to the Regulations, edible cannabis means a substance or mixture of substances that contains any part of a cannabis plant, including the phytocannabinoids produced or found in that plant and any substance identical to any of those phytocannabinoids, and which is intended to be consumed therefrom.
Way what food. To achieve these objectives, the Amending Regulation provides general information on the sale, content and specifications of the product, packaging and licensing requirements for new classes of cannabis in general. Due to the conditions included in the WHO recommendations, the Commission did not vote on the recommendation relating to the elimination of dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) from the 1971 Convention. .